CAMP4 TherapeuticsCAMP

13F holders, Q4 2024 (December 31)
36holders
1famous investor
$5.22avg. 13F price*

At the end of Q4 2024, 36 institutions reported holding CAMP4 Therapeutics Corp. (CAMP) in their 13F filings. The largest holders were Enavate Sciences Gp, LLC ($19.8M), 5AM Venture Management, LLC ($15.3M) and a16z Capital Management, L.L.C. ($11.1M). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
CAMP4 Therapeutics Corp.
CUSIP
13463J101
Latest filing quarter
Q2 2026

History

Number of 13F holders

020406080 Q4 2024: 36Q4 2024Q1 2025: 39Q1 2025Q2 2025: 29Q2 2025Q3 2025: 29Q3 2025Q4 2025: 40Q4 2025Q1 2026: 46Q1 2026Q2 2026: 61Q2 2026

Total Exit/New Position Q4 2024

InstitutionsTotal Value
New Positions36$47.3M
Exits0$0

Ownership 36 holders

Enavate Sciences Gp, LLC 14.19% — 3,785,802 $19.8M
5AM Venture Management, LLC 3.65% New 2,927,915 $15.3M
a16z Capital Management, L.L.C. 1.49% New 2,125,339 $11.1M
HarbourVest Partners LLC 3.28% New 1,271,948 $6.6M
FMR LLC 0.00% New 755,025 $3.9M
Franklin Resources Inc. 0.00% New 635,000 $3.3M
BlackRock, Inc. 0.00% New 265,370 $1.4M
Alyeska Investment Group, L.P. 0.00% New 200,000 $1.0M
Citadel Advisors 0.00% New 200,000 $1.0M
Vanguard Group Inc. 0.00% New 187,916 $981K
Geode Capital Management, LLC 0.00% New 145,086 $757K
Victory Capital Management Inc. 0.00% New 62,300 $325K
Northern Trust Corp. 0.00% New 51,860 $271K
Rhumbline Advisers 0.00% New 49,789 $260K
Norges Bank 0.00% New 35,000 $183K
JPMorgan Chase & Co. 0.00% New 21,272 $111K
State Street Corp. 0.00% New 20,500 $107K
Goldman Sachs Group Inc. 0.00% New 17,490 $91K
Charles Schwab Investment Management Inc. 0.00% New 16,685 $87K
Bank of America Corp. 0.00% New 16,459 $86K
Morgan Stanley 0.00% New 14,261 $74K
Barclays PLC 0.00% New 10,670 $56K
UBS Group AG 0.00% New 10,308 $54K
Citigroup Inc. 0.00% New 5,440 $28K
Sandia Investment Management LP 0.05% New 5,000 $26K
Tower Research Capital LLC (TRC) 0.00% New 3,680 $19K
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 0.00% New 3,630 $19K
Wells Fargo & Company 0.00% New 3,576 $19K
Corebridge Financial, Inc. 0.00% New 3,423 $18K
Ameritas Investment Partners, Inc. 0.00% New 720 $4K
Legal & General Group Plc 0.00% New 708 $4K
California State Teachers Retirement System 0.00% New 542 $3K
BNP Paribas Financial Markets 0.00% New 538 $3K
Royal Bank of Canada 0.00% New 504 $2K
Amalgamated Bank 0.00% New 235 $1K
Sterling Capital Management LLC 0.00% New 112 $585

"% of holder's portfolio" is CAMP's weight in each manager's 13F, not the share of CAMP4 Therapeutics Corp. the manager owns.